ClinicalTrials.gg
Sign In
Status unknownNCT03321669Updated Mar 12, 2018

Impact of Diet on Capsule Endoscopy

An interventional study of Capsule endoscopy in Small Bowel Disease, sponsored by Hospital Britanico. Status unknown at 1 site in Argentina. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-03-12.

Sponsored by Hospital Britanico · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Capsule endoscopy studies are used for the diagnosis of small bowel mucosal lesions. Since capsule endoscopy depends on the small intestinal peristaltism, the food intake - especially the amount of fat ingested - after the ingestion of the capsule may have an impact on the capsule endoscopy transit time and thus its diagnostic yield. As a consequence, an open-label randomized pilot study was designed to determine wether increased dietary intake of fat after the ingestion of the capsule endoscopy may influence small intestinal transit time and thus the diagnosis of small bowel lesions.

02

Conditions studied

  • Small Bowel Disease
03

In context

Lead sponsor

Hospital Britanico is the lead sponsor of 3 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients undergoing capsule endoscopy study

Exclusion criteria

Exclusion Criteria:

  • Not being able to follow a diet with increased amount of fat
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Active comparator
    Increased Fat Diet

    Procedure: Capsule endoscopy

  • Sham comparator
    Low Fat Diet

    Procedure: Capsule endoscopy

Interventions

  • ProcedureCapsule endoscopy

    Ingestion of capsule endoscopy for the diagnosis of small bowel lesions

06

What researchers measure

Primary outcomes

  1. Small bowel transit time

    Time frame: 12 hours

07

Study locations

1 of 1 sites recruiting
  • Hospital Britanico
    Buenos Aires, 1012, Argentina
    Recruiting
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2017 (actual). Primary completion is estimated for Dec 2018, 13 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 23, 2017
First posted
Oct 26, 2017
StartActual
Oct 4, 2017
Primary completionEst.
Dec 1, 2018
CompletionEst.
Dec 1, 2018
Last update
Mar 12, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 12, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03321669
Lead sponsor
Hospital Britanico
Responsible party
Juan Sebastian Lasa (Principal Investigator, Hospital Britanico) — Principal investigator
First posted
Oct 26, 2017
Start date
Oct 4, 2017
Primary completion
Dec 1, 2018 (estimated)
Completion
Dec 1, 2018 (estimated)
Last update
Mar 12, 2018

Study contacts

Juan S Lasa, MD
Contact
drjuanslasa@gmail.com
(54911)40848182

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies from this sponsor

Hospital Britanico

Start the discussion